Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

182P - Evolution of lung cancer mortality in Spain: 1980-2022, a joinpoint analysis

Date

22 Mar 2024

Session

Poster Display session

Topics

Population Risk Factor

Tumour Site

Presenters

Alberto Ruano-Ravina

Citation

Annals of Oncology (2024) 9 (suppl_3): 1-6. 10.1016/esmoop/esmoop102576

Authors

A. Ruano-Ravina, M. Pérez-Ríos, C. Guerra Tort, C. Candal-Pedreira, G. Garcia, L. Martín-Gisbert, A. Teijeiro, J. Rey Brandariz

Author affiliations

  • Universidade de Santiago de Compostela, Santiago de Compostela/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 182P

Background

Lung cancer in Spain is the first leading cause of cancer mortality in men and the third in women. This study analyzes the evolution of lung cancer mortality in Spain for both sexes from 1980 to 2022.

Methods

Lung cancer mortality data (ICD-10: C33-C34) and the population needed to calculate lung cancer mortality rates were obtained from the National Institute of Statistics. Lung cancer mortality rates were calculated for the years 1980 to 2022, both crude and age-adjusted using the direct method. Joinpoint regression models were used to analyze the trend of the adjusted rates. Annual percentage changes (APC) and their 95% confidence intervals (95%CI) were calculated.

Results

From 1980 to 2022, lung cancer caused 745,182 deaths in Spain, with 84.9% (632,907 deaths) occurring in men and 15.1% (112,275 deaths) occurring in women. The crude mortality rate for lung cancer in men increased until the beginning of the 21st century and has since stabilized. The crude mortality rate for men increased by 73.9%, from 41.5 deaths per 100,000 population in 1980 to 72.1 deaths in 2022. The mortality rate among women increased by 300.3% over the same period, rising from 6.2 deaths per 100,000 population in 1980 to 24.7 deaths in 2022. When analyzing the trend of the adjusted rates in men, three periods were detected. The first period showed an increasing trend between 1980-1993 (APC = 2.7 [95%CI 2.4 to 2.9]). The second and third periods both showed a decreasing trend; the first between 1993-2006 (APC = -0.6 [95%CI -0.9 to -0.3)], and the second between 2006-2022 (APC = -1.8 [95%CI -2.0 to -1.6]). In women, three periods were also detected. During the period of 1980-1989, there was a decreasing trend (APC = -1.0 [95%CI -1.7 to -0.3]). Between 1989-1999 and 1999-2022, there was an increasing trend in lung cancer mortality rates (APC: 1989-1999 = 1.6 [95%CI 0.9 to 2.3]; APC: 1999-2022 = 3.8 [95%CI 3.6 to 4.0]).

Conclusions

In recent years, lung cancer mortality rate has increased in Spanish women, while in men has stabilized. The adjusted rates show a decrease in men, which may explain the stabilization observed in the crude rates due to the aging of the population. The rate of increase in lung cancer death rates in women has doubled since 1999, highlighting the need for immediate preventive measures to curb this trend.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.